A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer

✍ Scribed by Lin, N. U.; Seah, D. S.; Gelman, R.; Desantis, S.; Mayer, E. L.; Isakoff, S.; DiPiro, P.; Krop, I. E.; Come, S. E.; Weckstein, D.; Winer, E. P.; Burstein, H. J.

• Book ID: 121634080
• Publisher: Springer US
• Year: 2013
• Tongue: English
• Weight: 258 KB
• Volume: 139
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-013-2551-9